Biotechnology

Earnings

UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround

UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday,

Read More
Business

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec. 19, 2025.

Read More
Business

Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey |

Read More
Business

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. 

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of

Read More
Business

Inside the dealmaking that pushed Trump to reclassify pot, expand access

President Donald Trump’s move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way

Read More
Business

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth

Read More
Business

Trump signs executive order reclassifying cannabis, opening door to broader weed access

U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C.,

Read More
Business

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov.

Read More
Business

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in

Read More
Business

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight

Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.